(2019) The combination of sofosbuvir and daclatasvir is well tolerated and extremely effective in treating patients with hepatitis C with severe renal impairment including hemodialysis patinets. Journal of Hepatology. E233-E233. ISSN 0168-8278
Full text not available from this repository.
Official URL: http://apps.webofknowledge.com/InboundService.do?F...
Abstract
The combination of sofosbuvir and daclatasvir is well tolerated and extremely effective in treating patients with hepatitis C with severe renal impairment including hemodialysis patinets
| Item Type: | Article |
|---|---|
| Keywords: | The combination of sofosbuvir and daclatasvir is well tolerated and extremely effective in treating patients with hepatitis C with severe renal impairment including hemodialysis patinets |
| Subjects: | WJ Urogenital System |
| Divisions: | Other |
| Page Range: | E233-E233 |
| Journal or Publication Title: | Journal of Hepatology |
| Journal Index: | ISI |
| Volume: | 70 |
| Identification Number: | https://doi.org/10.1016/S0618-8278(19)30437-2 |
| ISSN: | 0168-8278 |
| Depositing User: | Zahra Otroj |
| URI: | http://eprints.mui.ac.ir/id/eprint/10090 |
Actions (login required)
 |
View Item |